CN1876146A - A Chinese medicine for treating cardiovascular and cerebrovascular disease - Google Patents

A Chinese medicine for treating cardiovascular and cerebrovascular disease Download PDF

Info

Publication number
CN1876146A
CN1876146A CNA200510046620XA CN200510046620A CN1876146A CN 1876146 A CN1876146 A CN 1876146A CN A200510046620X A CNA200510046620X A CN A200510046620XA CN 200510046620 A CN200510046620 A CN 200510046620A CN 1876146 A CN1876146 A CN 1876146A
Authority
CN
China
Prior art keywords
radix
fructus
rhizoma
chinese medicine
cerebrovascular disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA200510046620XA
Other languages
Chinese (zh)
Other versions
CN100475261C (en
Inventor
李东坡
Original Assignee
李东坡
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 李东坡 filed Critical 李东坡
Priority to CNB200510046620XA priority Critical patent/CN100475261C/en
Publication of CN1876146A publication Critical patent/CN1876146A/en
Application granted granted Critical
Publication of CN100475261C publication Critical patent/CN100475261C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a Chinese medicinal composition for treating arteriosclerosis, coronary disease and cerebral thrombus, which is prepared from 28 kinds of Chinese medicinal herbs including astragalus root, Chinese angelica root and pseudo-ginseng.

Description

A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease such as arteriosclerosis, coronary heart disease, cerebral thrombosis.
Technical background
Class persistent ailments such as cardiovascular and cerebrovascular disease, cerebral infarction sequela and coronary heart disease belong to commonly encountered diseases, frequently-occurring disease, be mainly in middle-aged and elderly people, its sickness rate, mortality rate and disability rate are all than higher, disability rate is up to 70~80%, and still lack special effect medicine therapeutic at present, as the conventional Chinese medicine " storax pill for treating coronary heart disease " for the treatment of coronary heart disease is mainly by Styrax, Lignum Santali Albi, Borneolum Syntheticum, Olibanum, fine Radix Aucklandiae assembly, and the clinical practice total effective rate is about 70%, and average cure rate is 50~60%; Also as BUCHANG NAOXINTONG, class Chinese medicines such as brain peace sheet have certain curative effect to the treatment cardiovascular and cerebrovascular disease, take also more conveniently, finally determine but therapeutic effect is still difficult, and common bounce-back and recurrence after the medication, the course of treatment is long, curative effect is undesirable.
Summary of the invention
The objective of the invention is to develop a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease, utilize this medicine can reach significant curative effect, cure the back and be difficult for the bounce-back recurrence, the course of treatment is shorter, and various complication such as treatment arteriosclerosis, coronary heart disease, cerebral thrombosis, hyperlipidemia are had specially good effect.
The main effect of general similar Chinese medicine is a blood-activating and qi-promoting, the thromboembolism preventing collateral dredging, invigorating the liver and kidney is promoted blood circulation active, the expelling wind and removing dampness of having one's ideas straightened out, vessel softening wall, promoting blood circulation and stopping pain, and medicine of the present invention is except that having above-mentioned effect, main characteristics are that medicine can decompose and dissolve thrombosis stasis of blood piece rapidly in blood, can thoroughly remove alluvial dirty on blood vessel wall, get rid of the objectionable impurities in the blood.
Technical solution of the present invention is: made by 28 flavor raw material of Chinese medicine assembly such as the Radix Astragali, Radix Angelicae Sinensis, Radix Notoginseng, the weight proportion of each material component is:
The Radix Astragali 30~90g, Radix Angelicae Sinensis 10~20g, Radix Notoginseng 10~25g,
Semen Persicae 10~25g, Flos Carthami 10~20g, Radix Salviae Miltiorrhizae 15~40g,
Rhizoma Chuanxiong 5~15g, Pheretima 5~15g, Sanguis Draxonis 5~25g,
Radix Platycodonis 5~15g, Radix Gentianae 10~30g, Styrax 5~20g,
Radix Bupleuri 3~15g, Fructus Aurantii 12~20g, Lignum Aquilariae Resinatum 10~25g,
Radix Paeoniae Rubra 12~30g, the Radix Rehmanniae 10~20g, Radix Achyranthis Bidentatae 10~25g,
2~4 of Agkistrodons, Fructus Amomi 10~25g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 10~25g,
White bandit 10~20g, Endothelium Corneum Gigeriae Galli 10~25g, Rhizoma Acori Graminei 10~25g,
Radix Polygalae 10~30g, Semen Platycladi 10~30g, Radix Et Rhizoma Rhei 10~25g,
Radix Glycyrrhizae 10~25g.
The present invention can also be mixed with by the following weight material component:
The Radix Astragali 40~80g, Radix Angelicae Sinensis 10~20g, Radix Notoginseng 10~20g,
Semen Persicae 15~25g, Flos Carthami 10~15g, Radix Salviae Miltiorrhizae 20~40g,
Rhizoma Chuanxiong 8~10g, Pheretima 8~10g, Sanguis Draxonis 10~20g,
Radix Platycodonis 8~15g, Radix Gentianae 15~25g, Styrax 10~15g,
Radix Bupleuri 5~15g, Fructus Aurantii 15~18g, Lignum Aquilariae Resinatum 10~15g,
Radix Paeoniae Rubra 15~25g, the Radix Rehmanniae 15~20g, Radix Achyranthis Bidentatae 15~20g,
2~3 of Agkistrodons, Fructus Amomi 15~20g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 15~20g,
White bandit 10~15g, Endothelium Corneum Gigeriae Galli 10~20g, Rhizoma Acori Graminei 10~15g,
Radix Polygalae 10~20g, Semen Platycladi 10~20g, Radix Et Rhizoma Rhei 10~20g,
Radix Glycyrrhizae 10~15g.
The present invention can also be mixed with by the following weight material component:
Radix Astragali 60g, Radix Angelicae Sinensis 15g, Radix Notoginseng 15g,
Semen Persicae 20g, Flos Carthami 15g, Radix Salviae Miltiorrhizae 30g,
Rhizoma Chuanxiong 10g, Pheretima 10g, Sanguis Draxonis 15g,
Radix Platycodonis 10g, Radix Gentianae 20g, Styrax 12g,
Radix Bupleuri 10g, Fructus Aurantii 18g, Lignum Aquilariae Resinatum 15g,
Radix Paeoniae Rubra 20g, Radix Rehmanniae 15g, Radix Achyranthis Bidentatae 18g,
3 of Agkistrodons, Fructus Amomi 20g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 20g,
White bandit 15g, Endothelium Corneum Gigeriae Galli 15g, Rhizoma Acori Graminei 15g,
Radix Polygalae 15g, Semen Platycladi 15g, Radix Et Rhizoma Rhei 15g,
Radix Glycyrrhizae 15g.
This medicine is pressed the conventional preparation method of Chinese medicine, can be made into dosage forms such as powder capsule, pill, water preparation.
According to clinical practice 206 routine observation of curative effect, curative effect of medication of the present invention is remarkable, and relapse rate is lower than 2%, and be 15~30 days the general course of treatment, day twice (powder capsule) of clothes, and each 5~7g, basic recovery about 150 days of the course of treatment of thrombosis patient is normal.
The main effect of the present invention: can thoroughly remove the long-pending thing of the stasis of blood on the blood vessel wall, get rid of the objectionable impurities in the blood, reach the blood fat reducing blood circulation promoting and blood stasis dispelling, pass through promote blood circulation, reducing swelling and alleviating pain, thromboembolism preventing collateral dredging, pain relieving eliminating stagnation, endogenous wind stopping relieving convulsion, nourishing the liver and kidney, removing dampness are regulated the flow of vital energy, the purpose of nourishing qi and blood, make that microcirculation is fully improved in the body.Cure mainly: arteriosclerosis, hyperlipidemia, coronary heart disease, cerebral thrombosis, hypertension, hyperlipidemia, coronary heart disease complication, hyperlipidemia arteriosclerosis complication.
Observation on Clinical Application of the present invention the results are shown in following table:
The disease type The course of treatment (my god) Case load Cure (example) Cure rate (%) Effectively (example) Total effective rate (%)
Hyperlipidemia 30 55 53 96.4 55 100
Arteriosclerosis 30 50 48 96 50 100
Cerebral thrombosis 30 30 25 83.3 28 93.3
Coronary heart disease and hypertension+hyperlipidemia+coronary heart disease complication 30 46 39 84.8 46 100
Hyperlipidemia, arteriosclerosis complication 30 25 22 88 25 100
Below by embodiment the present invention is elaborated:
Embodiment 1:
Radix Astragali 40g, Radix Angelicae Sinensis 10g, Radix Notoginseng 15g, Semen Persicae 15g, Flos Carthami 10g, Radix Salviae Miltiorrhizae 20g, Rhizoma Chuanxiong 8g, Pheretima 8g, Sanguis Draxonis 10g, Radix Platycodonis 8g, Radix Gentianae 15g, Styrax 10g, Radix Bupleuri 5g, Fructus Aurantii 15g, Lignum Aquilariae Resinatum 10g, Radix Paeoniae Rubra 15g, Radix Rehmanniae 15g, Radix Achyranthis Bidentatae 15g, 2 of Agkistrodons, Fructus Amomi 15g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 15g, white bandit 10g, Endothelium Corneum Gigeriae Galli 10g, Rhizoma Acori Graminei 10g, Radix Polygalae 10g, Semen Platycladi 10g, Radix Et Rhizoma Rhei 10g, Radix Glycyrrhizae 10g.
Embodiment 2:
Radix Astragali 60g, Radix Angelicae Sinensis 15g, Radix Notoginseng 15g, Semen Persicae 20g, Flos Carthami 15g, Radix Salviae Miltiorrhizae 30g, Rhizoma Chuanxiong 10g, Pheretima 10g, Sanguis Draxonis 15g, Radix Platycodonis 10g, Radix Gentianae 20g, Styrax 12g, Radix Bupleuri 10g, Fructus Aurantii 18g, Lignum Aquilariae Resinatum 15g, Radix Paeoniae Rubra 20g, Radix Rehmanniae 15g, Radix Achyranthis Bidentatae 18g, 3 of Agkistrodons, Fructus Amomi 20g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 20g, white bandit 15g, Endothelium Corneum Gigeriae Galli 15g, Rhizoma Acori Graminei 15g, Radix Polygalae 15g, Semen Platycladi 15g, Radix Et Rhizoma Rhei 15g, Radix Glycyrrhizae 15g.
Embodiment 3:
Radix Astragali 80g, Radix Angelicae Sinensis 20g, Radix Notoginseng 20g, Semen Persicae 25g, Flos Carthami 15g, Radix Salviae Miltiorrhizae 40g, Rhizoma Chuanxiong 10g, Pheretima 10g, Sanguis Draxonis 20g, Radix Platycodonis 15g, Radix Gentianae 25g, Styrax 15g, Radix Bupleuri 15g, Fructus Aurantii 18g, Lignum Aquilariae Resinatum 15g, Radix Paeoniae Rubra 25g, Radix Rehmanniae 20g, Radix Achyranthis Bidentatae 20g, 3 of Agkistrodons, Fructus Amomi 20g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 20g, white bandit 15g, Endothelium Corneum Gigeriae Galli 20g, Rhizoma Acori Graminei 15g, Radix Polygalae 20g, Semen Platycladi 20g, Radix Et Rhizoma Rhei 20g, Radix Glycyrrhizae 15g.

Claims (3)

1, a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease is characterized in that it is mixed with by the following weight material component:
The Radix Astragali 30~90g, Radix Angelicae Sinensis 10~20g, Radix Notoginseng 10~25g,
Semen Persicae 10~25g, Flos Carthami 10~20g, Radix Salviae Miltiorrhizae 15~40g,
Rhizoma Chuanxiong 5~15g, Pheretima 5~15g, Sanguis Draxonis 5~25g,
Radix Platycodonis 5~15g, Radix Gentianae 10~30g, Styrax 5~20g,
Radix Bupleuri 3~15g, Fructus Aurantii 12~20g, Lignum Aquilariae Resinatum 10~25g,
Radix Paeoniae Rubra 12~30g, the Radix Rehmanniae 10~20g, Radix Achyranthis Bidentatae 10~25g,
2~4 of Agkistrodons, Fructus Amomi 10~25g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 10~25g,
White bandit 10~20g, Endothelium Corneum Gigeriae Galli 10~25g, Rhizoma Acori Graminei 10~25g,
Radix Polygalae 10~30g, Semen Platycladi 10~30g, Radix Et Rhizoma Rhei 10~25g,
Radix Glycyrrhizae 10~25g.
2,, it is characterized in that it is mixed with by the following weight material component according to the Chinese medicine of the described treatment cardiovascular and cerebrovascular disease of claim 1:
The Radix Astragali 40~80g, Radix Angelicae Sinensis 10~20g, Radix Notoginseng 10~20g,
Semen Persicae 15~25g, Flos Carthami 10~15g, Radix Salviae Miltiorrhizae 20~40g,
Rhizoma Chuanxiong 8~10g, Pheretima 8~10g, Sanguis Draxonis 10~20g,
Radix Platycodonis 8~15g, Radix Gentianae 15~25g, Styrax 10~15g,
Radix Bupleuri 5~15g, Fructus Aurantii 15~18g, Lignum Aquilariae Resinatum 10~15g,
Radix Paeoniae Rubra 15~25g, the Radix Rehmanniae 15~20g, Radix Achyranthis Bidentatae 15~20g,
2~3 of Agkistrodons, Fructus Amomi 15~20g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 15~20g,
White bandit 10~15g, Endothelium Corneum Gigeriae Galli 10~20g, Rhizoma Acori Graminei 10~15g,
Radix Polygalae 10~20g, Semen Platycladi 10~20g, Radix Et Rhizoma Rhei 10~20g,
Radix Glycyrrhizae 10~15g.
3,, it is characterized in that it is mixed with by the following weight material component according to the Chinese medicine of the described treatment cardiovascular and cerebrovascular disease of claim 1:
Radix Astragali 60g, Radix Angelicae Sinensis 15g, Radix Notoginseng 15g,
Semen Persicae 20g, Flos Carthami 15g, Radix Salviae Miltiorrhizae 30g,
Rhizoma Chuanxiong 10g, Pheretima 10g, Sanguis Draxonis 15g,
Radix Platycodonis 10g, Radix Gentianae 20g, Styrax 12g,
Radix Bupleuri 10g, Fructus Aurantii 18g, Lignum Aquilariae Resinatum 15g,
Radix Paeoniae Rubra 20g, Radix Rehmanniae 15g, Radix Achyranthis Bidentatae 18g,
3 of Agkistrodons, Fructus Amomi 20g, JIAOSANXIAN (Fructus Crataegi, Fructus Hordei Germinatus, Massa Medicata Fermentata) 20g,
White bandit 15g, Endothelium Corneum Gigeriae Galli 15g, Rhizoma Acori Graminei 15g,
Radix Polygalae 15g, Semen Platycladi 15g, Radix Et Rhizoma Rhei 15g,
Radix Glycyrrhizae 15g.
CNB200510046620XA 2005-06-10 2005-06-10 A Chinese medicine for treating cardiovascular and cerebrovascular disease Expired - Fee Related CN100475261C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB200510046620XA CN100475261C (en) 2005-06-10 2005-06-10 A Chinese medicine for treating cardiovascular and cerebrovascular disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB200510046620XA CN100475261C (en) 2005-06-10 2005-06-10 A Chinese medicine for treating cardiovascular and cerebrovascular disease

Publications (2)

Publication Number Publication Date
CN1876146A true CN1876146A (en) 2006-12-13
CN100475261C CN100475261C (en) 2009-04-08

Family

ID=37508816

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB200510046620XA Expired - Fee Related CN100475261C (en) 2005-06-10 2005-06-10 A Chinese medicine for treating cardiovascular and cerebrovascular disease

Country Status (1)

Country Link
CN (1) CN100475261C (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101721572B (en) * 2009-12-30 2011-05-25 南京中医药大学 Traditional Chinese medicine compound preparation for treating hemorrhagic apoplexy, preparation method and application thereof
CN101306169B (en) * 2008-07-18 2011-10-12 娄秀环 Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease
CN101791375B (en) * 2009-12-22 2012-05-23 沈阳亿灵医药科技有限公司 Chinese compound preparation for prevention and treatment of gynecological hemorrhagic disease
CN104189314A (en) * 2014-09-28 2014-12-10 陈远征 Pharmaceutical composition for treating hyperlipidemia with phlegm and turbid repression syndrome
CN104758438A (en) * 2015-03-19 2015-07-08 罗翔 Traditional Chinese medicinal composition for treating heart blood stasis type coronary heart disease
CN104784615A (en) * 2015-03-26 2015-07-22 哈尔滨医科大学 Traditional Chinese medicine composition for preventing and treating hyperlipidaemia, as well as preparation method and application of traditional Chinese medicine composition
CN106177727A (en) * 2016-08-05 2016-12-07 青岛市中心血站 A kind of pharmaceutical composition the most smooth for vein haemospasia

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104547346A (en) * 2013-10-23 2015-04-29 李杨林 Traditional Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases and supplying blood and oxygen

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101306169B (en) * 2008-07-18 2011-10-12 娄秀环 Traditional Chinese medicine for treating cardiovascular and cerebrovascular disease
CN101791375B (en) * 2009-12-22 2012-05-23 沈阳亿灵医药科技有限公司 Chinese compound preparation for prevention and treatment of gynecological hemorrhagic disease
CN101721572B (en) * 2009-12-30 2011-05-25 南京中医药大学 Traditional Chinese medicine compound preparation for treating hemorrhagic apoplexy, preparation method and application thereof
CN104189314A (en) * 2014-09-28 2014-12-10 陈远征 Pharmaceutical composition for treating hyperlipidemia with phlegm and turbid repression syndrome
CN104189314B (en) * 2014-09-28 2017-09-15 张毅 It is a kind of to treat the turbid pharmaceutical composition for checking card high fat of blood of phlegm
CN104758438A (en) * 2015-03-19 2015-07-08 罗翔 Traditional Chinese medicinal composition for treating heart blood stasis type coronary heart disease
CN104784615A (en) * 2015-03-26 2015-07-22 哈尔滨医科大学 Traditional Chinese medicine composition for preventing and treating hyperlipidaemia, as well as preparation method and application of traditional Chinese medicine composition
CN106177727A (en) * 2016-08-05 2016-12-07 青岛市中心血站 A kind of pharmaceutical composition the most smooth for vein haemospasia

Also Published As

Publication number Publication date
CN100475261C (en) 2009-04-08

Similar Documents

Publication Publication Date Title
CN1150922C (en) Medicated wine for treating rheumatism, rheumatoid disease and other arthralgia
CN100475261C (en) A Chinese medicine for treating cardiovascular and cerebrovascular disease
CN102058673B (en) Chinese medicine composition for expelling wind and removing dampness and preparation method thereof
CN1966003A (en) Externally applied medicament for treating rheumatism
CN1356138A (en) Medicine for treating cardiovascular and cerebrovascular diseases of old people
CN101991780A (en) Chinese material medical preparation for treating apoplexy
CN1285354C (en) Medicine for treating cerebral infarction
CN1336225A (en) Cerebral thrombus treating traditional Chinese medicine
CN1927240A (en) Traditional Chinese medicine mask composition for depigmenting
CN1966067A (en) Medicament for treating aplastic anemia
CN1868528A (en) Traditional Chinese medicine prepns. for treating cardiovascular and cerebrovascular diseases
CN1245173C (en) Medicine composition for treating liver fibrillation and liver cirrhosis and its prepn process
CN1060938C (en) Chinese medicinal instant powder for treatment of B-hepatitis
CN105878775A (en) Medicine for treating cardiovascular diseases
CN1788754A (en) Oral medicine for treating hyperosteogeny-pellet for treating bone pain
CN1051471C (en) Drug composition for curing osteoporosis
CN1195541C (en) Medicine combination for treating chronic hepatitis B
CN1223886A (en) Pathogenic factor eliminating and healthy energy supporting anticancer medicine
CN1183937C (en) Compound Chinese medicine preparation of damnacanthus
CN1907345A (en) Chinese traditional medicine composition for treating cerebral apoplexy
CN1857630A (en) Proteinuria treating Chinese medicine and its preparing method and use
CN1742955A (en) Chinese medicine for treating nipple discharge
CN110841007B (en) Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof
CN1850192A (en) Medicine composition for treating cerebral embolism sequela and rheumatoid arthritis and preparing method
CN100335111C (en) Medicine for rheumatism and its preparation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090408

Termination date: 20110610